MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
2009
|
| _version_ | 1797075272898445312 |
|---|---|
| author | Takahashi, O Komaki, R Smith, P Ryan, A Jurgensmeier, J Welsh, J Jacoby, J Hosho, K Korshunova, M Erez, B Herbst, R O'Reilly, MS |
| author_facet | Takahashi, O Komaki, R Smith, P Ryan, A Jurgensmeier, J Welsh, J Jacoby, J Hosho, K Korshunova, M Erez, B Herbst, R O'Reilly, MS |
| author_sort | Takahashi, O |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T23:48:06Z |
| format | Journal article |
| id | oxford-uuid:71a55fb4-953c-4598-bcc0-5097ca36f15f |
| institution | University of Oxford |
| last_indexed | 2024-03-06T23:48:06Z |
| publishDate | 2009 |
| record_format | dspace |
| spelling | oxford-uuid:71a55fb4-953c-4598-bcc0-5097ca36f15f2022-03-26T19:45:02ZMEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranibJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:71a55fb4-953c-4598-bcc0-5097ca36f15fSymplectic Elements at Oxford2009Takahashi, OKomaki, RSmith, PRyan, AJurgensmeier, JWelsh, JJacoby, JHosho, KKorshunova, MErez, BHerbst, RO'Reilly, MS |
| spellingShingle | Takahashi, O Komaki, R Smith, P Ryan, A Jurgensmeier, J Welsh, J Jacoby, J Hosho, K Korshunova, M Erez, B Herbst, R O'Reilly, MS MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib |
| title | MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib |
| title_full | MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib |
| title_fullStr | MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib |
| title_full_unstemmed | MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib |
| title_short | MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib |
| title_sort | mek1 2 blockade by azd6244 arry 142886 inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib |
| work_keys_str_mv | AT takahashio mek12blockadebyazd6244arry142886inhibitstumorgrowthandprogressioninanorthotopichumanlungadenocarcinomamodelwithenhancedefficacywhencombinedwithcediranib AT komakir mek12blockadebyazd6244arry142886inhibitstumorgrowthandprogressioninanorthotopichumanlungadenocarcinomamodelwithenhancedefficacywhencombinedwithcediranib AT smithp mek12blockadebyazd6244arry142886inhibitstumorgrowthandprogressioninanorthotopichumanlungadenocarcinomamodelwithenhancedefficacywhencombinedwithcediranib AT ryana mek12blockadebyazd6244arry142886inhibitstumorgrowthandprogressioninanorthotopichumanlungadenocarcinomamodelwithenhancedefficacywhencombinedwithcediranib AT jurgensmeierj mek12blockadebyazd6244arry142886inhibitstumorgrowthandprogressioninanorthotopichumanlungadenocarcinomamodelwithenhancedefficacywhencombinedwithcediranib AT welshj mek12blockadebyazd6244arry142886inhibitstumorgrowthandprogressioninanorthotopichumanlungadenocarcinomamodelwithenhancedefficacywhencombinedwithcediranib AT jacobyj mek12blockadebyazd6244arry142886inhibitstumorgrowthandprogressioninanorthotopichumanlungadenocarcinomamodelwithenhancedefficacywhencombinedwithcediranib AT hoshok mek12blockadebyazd6244arry142886inhibitstumorgrowthandprogressioninanorthotopichumanlungadenocarcinomamodelwithenhancedefficacywhencombinedwithcediranib AT korshunovam mek12blockadebyazd6244arry142886inhibitstumorgrowthandprogressioninanorthotopichumanlungadenocarcinomamodelwithenhancedefficacywhencombinedwithcediranib AT erezb mek12blockadebyazd6244arry142886inhibitstumorgrowthandprogressioninanorthotopichumanlungadenocarcinomamodelwithenhancedefficacywhencombinedwithcediranib AT herbstr mek12blockadebyazd6244arry142886inhibitstumorgrowthandprogressioninanorthotopichumanlungadenocarcinomamodelwithenhancedefficacywhencombinedwithcediranib AT oreillyms mek12blockadebyazd6244arry142886inhibitstumorgrowthandprogressioninanorthotopichumanlungadenocarcinomamodelwithenhancedefficacywhencombinedwithcediranib |